Table 3.

Proportion of patient eligible for MR-HIFU treatment

Inclusion criteria	Proportion (%)
Tumour ≤ 3 cm	78.6
No lymph node metastasis	65.0
No lobular subtype	90.2
No EIC	84.6
No previous surgery	91.3
No renal insufficiency	97.3
Not multifocal	82.0
No BRCA mutation	97.4
Tumour reachable	66.3
Distance to skin ≥ 1 cm	65.0
Eligible patientsa	11.9

EIC extensive intraductal component

^ai.e. all of the inclusion criteria present